APA

Mandal Mahendra Narayan, University of Delhi. Faculty of Medical Sciences. Department of Surgery, Dr A N Sinha Supervisor & University of Delhi. Faculty of Medical Sciences. Department of Surgery. (1999). Combined low dose immunotherapy (BCG+Interferon-alpha-2b) in the management of superficial transitional cell carcinoma of urinary bladder. : .

Chicago

Mandal Mahendra Narayan, University of Delhi. Faculty of Medical Sciences. Department of Surgery, Dr A N Sinha Supervisor and University of Delhi. Faculty of Medical Sciences. Department of Surgery. 1999. Combined low dose immunotherapy (BCG+Interferon-alpha-2b) in the management of superficial transitional cell carcinoma of urinary bladder. : .

Harvard

Mandal Mahendra Narayan, University of Delhi. Faculty of Medical Sciences. Department of Surgery, Dr A N Sinha Supervisor and University of Delhi. Faculty of Medical Sciences. Department of Surgery. (1999). Combined low dose immunotherapy (BCG+Interferon-alpha-2b) in the management of superficial transitional cell carcinoma of urinary bladder. : .

MLA

Mandal Mahendra Narayan, University of Delhi. Faculty of Medical Sciences. Department of Surgery, Dr A N Sinha Supervisor and University of Delhi. Faculty of Medical Sciences. Department of Surgery. Combined low dose immunotherapy (BCG+Interferon-alpha-2b) in the management of superficial transitional cell carcinoma of urinary bladder. : . 1999.